Rowland Thomas Andrew sold ANIP
February 11, 2026 · Form 4 insider transaction
Rowland Thomas Andrew sold 1,762 shares of ANI Pharmaceuticals, Inc. at $76.25 per share, a transaction worth $134.4K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,762
Price
$76.25
Total value
$134.4K
InsiderRowland Thomas Andrew
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after39,160
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,788 performance stock units, the grant of which was previously reported.; Includes 128 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c).